| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1002654807 |
| P356 | DOI | 10.1007/BF00177272 |
| P698 | PubMed publication ID | 8943096 |
| P2093 | author name string | J R Shapiro | |
| M E Berens | |||
| G Floyd-Smith | |||
| J I Garrison | |||
| S Treasurywala | |||
| P2860 | cites work | Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene | Q24297016 |
| Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA | Q24300964 | ||
| The human interferon alpha/beta receptor: characterization and molecular cloning | Q24313421 | ||
| The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. | Q55481603 | ||
| Regional heterogeneity in the DNA content of human gliomas. | Q55482588 | ||
| Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. | Q55490312 | ||
| The astrocyte mitogen, tumor necrosis factor-alpha, inhibits the proliferative effect of more potent adult human astrocyte mitogens, gamma-interferon and activated T-lymphocyte supernatants | Q57043331 | ||
| Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene | Q69364763 | ||
| Terminal transferase: use of the tailing of DNA and for in vitro mutagenesis | Q70165920 | ||
| T cell growth-promoting activity of interferon-gamma. Mitogenic effect of the recombinant cytokine on cells from a human T-chronic lymphocytic leukemia | Q72123219 | ||
| T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells | Q72715930 | ||
| Ordering S phase and M phase in the cell cycle | Q72790820 | ||
| Mitosis in transition | Q72790826 | ||
| Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences | Q24555798 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
| Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2 | Q28118615 | ||
| Interferons and their actions | Q28305734 | ||
| G1 phase progression: cycling on cue | Q29615162 | ||
| The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen | Q30988634 | ||
| Interferon inhibits the establishment of competence in Go/S-phase transition | Q34188638 | ||
| Cytokine triggered molecular pathways that control cell cycle arrest | Q35345229 | ||
| Biology and treatment of gliomas | Q35674397 | ||
| The failure of human leukocyte interferon to influence the growth of human glioma cell populations: in vitro and in vivo studies | Q36048399 | ||
| Tumor-suppressor genes: news about the interferon connection | Q36381763 | ||
| Tumor Heterogeneity and Intrinsically Chemoresistant Subpopulations in Freshly Resected Human Malignant Gliomas | Q37042939 | ||
| Synthesis and secretion of proteins resembling platelet-derived growth factor by human glioblastoma and fibrosarcoma cells in culture | Q37684542 | ||
| Interferons: biological and clinical effects | Q38210046 | ||
| A reliable method for northern blot analysis using synthetic oligonucleotide probes | Q38336883 | ||
| Progress toward therapeutic application of interferons, 1979–1983 | Q40112102 | ||
| Response and resistance to interferons and interacting cytokines. | Q40399529 | ||
| A pilot study of recombinant interferon beta (IFN-beta ser) in patients with recurrent glioma | Q40760111 | ||
| Invariant chain (CD74) gene regulation: Enhanced expression associated with activation of protein kinase Cδ in a murine B lymphoma cell line | Q41340296 | ||
| Human brain tumor--derived cell lines: growth rate reduced by human fibroblast interferon | Q43988517 | ||
| An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction | Q44194879 | ||
| Close link between reduction of c-myc expression by interferon and, G0/G1 arrest | Q44281539 | ||
| Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity | Q45091285 | ||
| The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables | Q48483676 | ||
| Effects of interferon and gangliosides on growth of cultured human glioma and fetal brain cells | Q48519692 | ||
| Flow cytometric analysis of antineoplastic effects of interferon-alpha, beta and gamma labelled with fluorescein isothiocyanate on cultured brain tumors | Q48613980 | ||
| Differential effects of tumor necrosis factor on the growth and differentiation of neuroblastoma and glioma cells | Q48729467 | ||
| Effect of human leukocyte interferon on malignant brain tumors | Q48801114 | ||
| Cytotoxicity of human beta-interferon produced in human glioma cells transfected with its gene by means of liposomes | Q54257568 | ||
| P4510 | describes a project that uses | NN | Q54930853 |
| NNR | Q54930858 | ||
| SK-AO2 | Q54953607 | ||
| AO2V4 | Q54750110 | ||
| GJC | Q54835863 | ||
| GJR | Q54835864 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell line | Q21014462 |
| P304 | page(s) | 213-223 | |
| P577 | publication date | 1996-12-01 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines | |
| P478 | volume | 30 |
| Q64972389 | A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models. |
| Q37629088 | Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy |
| Q37606683 | Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models |
| Q59132144 | Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation |
| Q47156728 | Cancer-Specific Inhibitory Effects of Genetically Engineered Stem Cells Expressing Cytosine Deaminase and Interferon-β Against Choriocarcinoma in Xenografted Metastatic Mouse Models |
| Q31013320 | Combining cytotoxic and immune-mediated gene therapy to treat brain tumors |
| Q55475333 | Cytotoxic effect through fas/APO-1 expression due to vitamin K in human glioma cells. |
| Q47817635 | Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells |
| Q40505312 | Interferon-alpha: regulatory effects on cell cycle and angiogenesis |
| Q47848940 | Interferon-beta inhibits mitogen induced astrocyte proliferation in vitro |
| Q81333268 | Interferon-beta protects astrocytes against tumour necrosis factor-induced apoptosis via activation of p38 mitogen-activated protein kinase |
| Q40661850 | Lack of interferon beta-induced radiosensitization in four out of five human glioblastoma cell lines |
| Q33294225 | Mechanisms of interferon-beta-induced survival in fetal and neonatal primary astrocytes |
| Q52973188 | Molecular mechanism of interferon alfa-mediated growth inhibition in human neuroendocrine tumor cells. |
| Q37302247 | Receptor density is key to the alpha2/beta interferon differential activities. |
Search more.